1990
DOI: 10.1172/jci114875
|View full text |Cite
|
Sign up to set email alerts
|

Macrophages cultured in vitro release leukotriene B4 and neutrophil attractant/activation protein (interleukin 8) sequentially in response to stimulation with lipopolysaccharide and zymosan.

Abstract: The capacity of lipopolysaccharide (LPS), zymosan, and calcium ionophore A23187 to induce neutrophil chemotactic activity (NCA), leukotriene B4 (LTB4), and neutrophil attractant/activation protein (NAP-1) release from human alveolar macrophages (AM) retrieved from normal nonsmokers was evaluated. LPS induced a dose-dependent release of LTB4 that began by 1 h, 4.0±3.2 ng/106 viable AM; peaked at 3 h, 24.7±13.5 ng/10' viable AM; and decreased by 24 h, 1.2±1.0 ng/106 viable AM (n = 8). Quantities of LTB4 in cell-… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

4
49
1

Year Published

1992
1992
2009
2009

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 113 publications
(54 citation statements)
references
References 48 publications
4
49
1
Order By: Relevance
“…LPS was also reported to increase LTB 4 production in both cell types (46,47). Therefore, neutrophils and macrophages may be other sources of LTB 4 in the bone marrow of mice suffering from bone resorption diseases.…”
Section: Discussionmentioning
confidence: 97%
“…LPS was also reported to increase LTB 4 production in both cell types (46,47). Therefore, neutrophils and macrophages may be other sources of LTB 4 in the bone marrow of mice suffering from bone resorption diseases.…”
Section: Discussionmentioning
confidence: 97%
“…During the inflammatory response, neutrophil migration and activation result mainly from the release of chemoattractants by resident cells, such as macrophages, mast cells or lymphocytes [38][39][40][41]. The neutrophil chemoattractant factors include TNF-a, IL-1b, plateletactivating factor (PAF), C5a, leukotriene B4 (LTB 4 ) and a variety of chemokines, including IL-8, growth-related oncogene-alpha (GRO-a), MIP-1a and stromal cellderived factor 1 (SDF-1) [42][43][44].…”
Section: Introductionmentioning
confidence: 99%
“…Indeed, the efficacy of the so-called disease modifying anti-inflammatory drugs in several inflammatory diseases, such as rheumatoid arthritis is usually associated with their ability to decrease neutrophil influx into the inflammatory site [36,37]. Therefore, strategies to limit neutrophil trafficking and/or activation have received attention as potential alternatives in the treatment of these diseases.During the inflammatory response, neutrophil migration and activation result mainly from the release of chemoattractants by resident cells, such as macrophages, mast cells or lymphocytes [38][39][40][41]. The neutrophil chemoattractant factors include TNF-a, IL-1b, plateletactivating factor (PAF), C5a, leukotriene B4 (LTB 4 ) and a variety of chemokines, including IL-8, growth-related oncogene-alpha (GRO-a), MIP-1a and stromal cellderived factor 1 (SDF-1) [42][43][44].…”
mentioning
confidence: 99%
“…LTB 4 is a lipoxygenase product of arachidonic acid metabolism and is generated primarily by polymorphonuclear (3,12) and mononuclear phagocytes (36). It has been identified, in chamber models (25) and other models of intravital microscopy (2,20), as a key mediator of leukocyte-endothelial cell interaction in intact organisms after ischemia-reperfusion injury and as a potent chemoattractant responsible for the recruitment of neutrophils to the site of inflammation (34).…”
Section: Discussionmentioning
confidence: 99%